Gilwan Kim

617 total citations
28 papers, 447 citations indexed

About

Gilwan Kim is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, Gilwan Kim has authored 28 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Psychiatry and Mental health, 9 papers in Pathology and Forensic Medicine and 8 papers in Rheumatology. Recurrent topics in Gilwan Kim's work include Migraine and Headache Studies (11 papers), Psychosomatic Disorders and Their Treatments (6 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Gilwan Kim is often cited by papers focused on Migraine and Headache Studies (11 papers), Psychosomatic Disorders and Their Treatments (6 papers) and Rheumatoid Arthritis Research and Therapies (6 papers). Gilwan Kim collaborates with scholars based in United States, United Kingdom and Austria. Gilwan Kim's co-authors include Xue Song, Yujin Park, Jessica A. Walsh, Peter Hur, Jeffrey Kaine, Jacqueline B. Palmer, Xue Song, Jamie C. Barner, Karen L. Rascati and Kristin M. Richards and has published in prestigious journals such as Headache The Journal of Head and Face Pain, Cephalalgia and Clinical Therapeutics.

In The Last Decade

Gilwan Kim

25 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gilwan Kim United States	13	207	118	83	80	74	28	447
Nisha Nigil Haroon Canada	11	349 1.7×	146 1.2×	85 1.0×	48 0.6×	58 0.8×	18	657
Valeria Nucera Italy	12	166 0.8×	97 0.8×	57 0.7×	117 1.5×	54 0.7×	19	477
Carolina Pérez-García Spain	13	166 0.8×	81 0.7×	14 0.2×	16 0.2×	72 1.0×	38	371
Sami Bahlas Saudi Arabia	11	169 0.8×	50 0.4×	41 0.5×	10 0.1×	51 0.7×	41	357
Adeel Nasir United States	4	235 1.1×	82 0.7×	35 0.4×	40 0.5×	46 0.6×	6	428
Orhun Çamurdan Türkiye	13	39 0.2×	27 0.2×	37 0.4×	112 1.4×	24 0.3×	35	567
Salim Dönmez Türkiye	13	135 0.7×	64 0.5×	41 0.5×	56 0.7×	27 0.4×	29	379
Philip Connor United Kingdom	11	45 0.2×	55 0.5×	129 1.6×	28 0.3×	233 3.1×	24	545
Upendra Yadav India	13	276 1.3×	15 0.1×	17 0.2×	52 0.7×	50 0.7×	28	462
K.P. Tiev France	10	82 0.4×	30 0.3×	58 0.7×	29 0.4×	18 0.2×	23	429

Countries citing papers authored by Gilwan Kim

Since Specialization

Citations

This map shows the geographic impact of Gilwan Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilwan Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilwan Kim more than expected).

Fields of papers citing papers by Gilwan Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilwan Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilwan Kim. The network helps show where Gilwan Kim may publish in the future.

Co-authorship network of co-authors of Gilwan Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Gilwan Kim. A scholar is included among the top collaborators of Gilwan Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilwan Kim. Gilwan Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Buse, Dawn C., Anthony J. Zagar, Robert E. Shapiro, et al.. (2025). Rates and risk factors for migraine progression using multiple definitions of progression: Results of the longitudinal OVERCOME ( US ) study. Headache The Journal of Head and Face Pain. 65(4). 589–607. 4 indexed citations

Ashina, Sait, Gilwan Kim, Dawn C. Buse, et al.. (2025). Patterns of calcitonin gene-related peptide monoclonal antibody use in people with migraine: Results of the OVERCOME (US) study. Cephalalgia. 45(6). 2235386299–2235386299.

Vu, Michelle, et al.. (2025). Monthly Headaches and Severity in Patients on Galcanezumab or Traditional Preventive Migraine Medication: A 24-Month Claims and Electronic Health Records Study. Neurology and Therapy. 14(3). 911–925.

Vu, Michelle, et al.. (2024). Health care resource utilization and direct costs incurred over 24 months after initiating galcanezumab or standard-of-care preventive migraine treatments in the United States. Journal of Managed Care & Specialty Pharmacy. 30(8). 792–804. 1 indexed citations

Seng, Elizabeth K., Christian Lampl, Lars Viktrup, et al.. (2024). Patients’ Experiences During the Long Journey Before Initiating Migraine Prevention with a Calcitonin Gene-Related Peptide (CGRP) Monoclonal Antibody (mAb). Pain and Therapy. 13(6). 1589–1615. 2 indexed citations

Kim, Gilwan, et al.. (2024). Healthcare Utilization, Costs, and Treatment Discontinuation in Adults with Episodic Migraine Initiating Galcanezumab Versus Rimegepant: A US Retrospective Claims Analysis. Advances in Therapy. 42(2). 918–934.

Jackson, James, et al.. (2024). Patient-reported outcomes related to migraine burden among patients treated with standard-of-care preventive medications or calcitonin gene-related monoclonal antibodies: a United States and Europe cross-sectional survey. Current Medical Research and Opinion. 40(12). 2179–2190. 2 indexed citations

Kong, Amanda M., et al.. (2021). Diagnostic Testing of Vaginitis: Improving the Value of Care. Population Health Management. 24(4). 515–524. 13 indexed citations

Bonafede, Machaon, et al.. (2020). Productivity Loss and Associated Costs Among Employed Patients Receiving Disease-Modifying Treatment for Multiple Sclerosis. PharmacoEconomics - Open. 5(1). 23–34. 5 indexed citations

10.

Kong, Amanda M., Gilwan Kim, Margaret Michalska, & Jennie H. Best. (2018). Costs of Disease Relapses Among Individuals with Granulomatosis, with Polyangiitis, or Microscopic Polyangiitis in the United States. Rheumatology and Therapy. 5(1). 159–170. 5 indexed citations

11.

Walsh, Jessica A., Xue Song, Gilwan Kim, & Yujin Park. (2018). Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set. Clinical Rheumatology. 37(7). 1869–1878. 52 indexed citations

12.

Burton, Barbara K., Kyle Bradford Jones, Stephen D. Cederbaum, et al.. (2018). Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria. Molecular Genetics and Metabolism. 125(3). 228–234. 69 indexed citations

13.

Kaine, Jeffrey, Xue Song, Gilwan Kim, Peter Hur, & Jacqueline B. Palmer. (2018). Higher Incidence Rates of Comorbidities in Patients with Psoriatic Arthritis Compared with the General Population Using U.S. Administrative Claims Data. Journal of Managed Care & Specialty Pharmacy. 25(1). 122–132. 79 indexed citations

14.

Walsh, Jessica A., Xue Song, Gilwan Kim, & Yujin Park. (2018). Healthcare Utilization and Direct Costs in Patients with Ankylosing Spondylitis Using a Large US Administrative Claims Database. Rheumatology and Therapy. 5(2). 463–474. 24 indexed citations

15.

Akbari, Mona, et al.. (2018). Use of Real-World Evidence to Characterize Clinical Outcomes in Patients Who Develop Acute Graft Versus Host Disease Undergoing Allogeneic Stem Cell Transplantation in the United States. Biology of Blood and Marrow Transplantation. 24(3). S308–S309. 1 indexed citations

16.

Kim, Gilwan, Jamie C. Barner, Karen L. Rascati, & Kristin M. Richards. (2016). Examining Time to Initiation of Biologic Disease-modifying Antirheumatic Drugs and Medication Adherence and Persistence Among Texas Medicaid Recipients With Rheumatoid Arthritis. Clinical Therapeutics. 38(3). 646–654. 15 indexed citations

17.

Raimundo, Karina, Amanda M. Farr, Gilwan Kim, & George F. Duna. (2015). Clinical and Economic Burden of Antineutrophil Cytoplasmic Antibody–associated Vasculitis in the United States. The Journal of Rheumatology. 42(12). 2383–2391. 35 indexed citations

18.

Gupte-Singh, Komal, Gilwan Kim, & Jamie C. Barner. (2015). Impact of comorbid depression on medication adherence and asthma-related healthcare costs in Texas Medicaid patients with asthma. Journal of Pharmaceutical Health Services Research. 6(4). 197–205. 3 indexed citations

19.

Tan, Xi, Chanhyun Park, Gilwan Kim, Isha Patel, & Jongwha Chang. (2014). Improving adherence to acne treatment: the emerging role of application software. Clinical Cosmetic and Investigational Dermatology. 7. 65–65. 18 indexed citations

20.

Corelli, Robin L., Briseis Aschebrook‐Kilfoy, Gilwan Kim, Peter J. Ambrose, & Karen Suchanek Hudmon. (2011). Availability of Tobacco and Alcohol Products in Los Angeles Community Pharmacies. Journal of Community Health. 37(1). 113–118. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact